| Intrinsic Valuation of: GLENMARK | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 37 | Market Cap | ₹656B | |||||
| 2021 | - | - (-) | P/E Ratio | 62 | Total Asset | ₹160B | |||||
| 2022 | ₹3B | - (-) | Net Income | ₹10B | Total Debt | ₹5B | |||||
| 2023 | ₹176M | -94.5% (-94.1%) | EBITDA | ₹21B | Total Liab | ₹72B | |||||
| 2024 | ₹-12B | -6701.7% (-6586.3%) | Opr Margin | 14.21 | Debt/Equity | 0.06 | |||||
| 2025 | ₹-16B | -35.5% (-19.9%) | PreTax Margin | 12.64 | BV/Share | 262 | |||||
| 5Y Average FCF | ₹-6B | 2.9% (-2233.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.01% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (2.9%) | ||||||||||
| 2026 | ₹2B | MBG Intrinsic Value | ₹335 | ||||||||
| 2027 | ₹2B | ||||||||||
| 2028 | ₹2B | ||||||||||
| 2029 | ₹2B | ||||||||||
| 2030 | ₹2B | ||||||||||
| 2031 | ₹2B | ||||||||||
| Terminal Value | ₹45B | Net Worth/Share | ₹314 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹38B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹17B | ₹178 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹5B | WACC | 6.5% | 170 | 181 | 195 | 213 | 237 | |||
| Equity Value | ₹50B | 7.1% | 155 | 164 | 174 | 187 | 203 | ||||
| Shares Outstanding | 282,200,809 | 7.8% | 144 | 150 | 158 | 168 | 180 | ||||
| 8.4% | 134 | 140 | 146 | 153 | 162 | ||||||
| DCF Intrinsic Value | ₹178 | 9.0% | 126 | 131 | 136 | 141 | 148 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||